<VariationArchive VariationID="424759" VariationName="NM_000092.4(COL4A4):c.[1320_1369+2del];[2320G&gt;C]" VariationType="CompoundHeterozygote" Accession="VCV000424759" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2016-02-27" MostRecentSubmission="2016-02-27">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Genotype VariationID="424759">
      <SimpleAllele AlleleID="223748" VariationID="242441">
        <GeneList>
          <Gene Symbol="COL4A4" FullName="collagen type IV alpha 4 chain" GeneID="1286" HGNC_ID="HGNC:2206" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>2q36.3</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="226967360" stop="227164488" display_start="226967360" display_stop="227164488" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="227867426" stop="228029274" display_start="227867426" display_stop="228029274" Strand="-" />
            </Location>
            <OMIM>120131</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_000092.4(COL4A4):c.1321_1369+3del</Name>
        <VariantType>Deletion</VariantType>
        <Location>
          <CytogeneticLocation>2q36.3</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227094122" stop="227094173" display_start="227094122" display_stop="227094173" variantLength="52" positionVCF="227094121" referenceAlleleVCF="TTACCACTTGATCCTGGGAGGCCCTGCAGGCCTGGTGCTCCAGGCAAGCCAGG" alternateAlleleVCF="T" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="227958838" stop="227958889" display_start="227958838" display_stop="227958889" variantLength="52" positionVCF="227958837" referenceAlleleVCF="TTACCACTTGATCCTGGGAGGCCCTGCAGGCCTGGTGCTCCAGGCAAGCCAGG" alternateAlleleVCF="T" />
        </Location>
        <HGVSlist>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_231" sequenceAccession="LRG_231" change="g.75387_75438del">
              <Expression>LRG_231:g.75387_75438del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.227958839_227958890del" Assembly="GRCh37">
              <Expression>NC_000002.11:g.227958839_227958890del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.227094123_227094174del" Assembly="GRCh38">
              <Expression>NC_000002.12:g.227094123_227094174del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_011592.1" sequenceAccession="NG_011592" sequenceVersion="1" change="g.75387_75438del">
              <Expression>NG_011592.1:g.75387_75438del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_000092.5" sequenceAccession="NM_000092" sequenceVersion="5" change="c.1321_1369+3del" MANESelect="true">
              <Expression>NM_000092.5:c.1321_1369+3del</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_231t1" sequenceAccession="LRG_231t1">
              <Expression>LRG_231t1:c.1321_1369+3del</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2023-07-08" DateCreated="2018-04-19" MostRecentSubmission="2024-06-20" NumberOfSubmissions="7" NumberOfSubmitters="6">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">16199547</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">21196518</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">24854265</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25307543</ID>
            </Citation>
            <DescriptionHistory Dated="2022-05-15">
              <Description>Pathogenic/Likely pathogenic</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2021-05-10">
              <Description>Pathogenic</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2018-06-04">
              <Description>no classification for the single variant</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2018-06-04">
              <Description>Pathogenic</Description>
            </DescriptionHistory>
            <ConditionList>
              <TraitSet ID="5740" Type="Disease" ContributesToAggregateClassification="false">
                <Trait ID="158" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Alport syndrome 3, autosomal dominant</ElementValue>
                    <XRef ID="Alport+Syndrome+Dominant+Type/336" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">ALPORT SYNDROME 3A, AUTOSOMAL DOMINANT</ElementValue>
                    <XRef Type="MIM" ID="104200" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Autosomal dominant Alport syndrome</ElementValue>
                    <XRef ID="MONDO:0007086" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Alport syndrome dominant type</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Renal failure and sensorineural hearing loss</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">ATS3A</ElementValue>
                    <XRef Type="MIM" ID="104200" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                    <XRef ID="NBK1207" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="624" />
                    <XRef ID="624" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301386</ID>
                    <ID Source="BookShelf">NBK1207</ID>
                  </Citation>
                  <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                    <ID Source="PubMed">22166944</ID>
                  </Citation>
                  <XRef ID="63" DB="Orphanet" />
                  <XRef ID="88918" DB="Orphanet" />
                  <XRef ID="C5882663" DB="MedGen" />
                  <XRef ID="MONDO:0007086" DB="MONDO" />
                  <XRef Type="MIM" ID="104200" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="5721" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="282" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Alport syndrome recessive type</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Nephropathy and deafness</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive Alport syndrome</ElementValue>
                    <XRef ID="MONDO:0008762" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">COL4A4 Alport Syndrome and Thin Basement Membrane Nephropathy</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE</ElementValue>
                    <XRef Type="MIM" ID="203780" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0003" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0002" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0004" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0001" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0005" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0011" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0001" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0002" DB="OMIM" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">ATS2</ElementValue>
                    <XRef Type="MIM" ID="203780" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                    <XRef ID="NBK1207" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="625" />
                    <XRef ID="625" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="keyword">COL4A3-Related Nephropathy</Attribute>
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="keyword">COL4A4-Related Nephropathy</Attribute>
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301386</ID>
                    <ID Source="BookShelf">NBK1207</ID>
                  </Citation>
                  <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                    <ID Source="PubMed">22166944</ID>
                  </Citation>
                  <XRef ID="63" DB="Orphanet" />
                  <XRef ID="88919" DB="Orphanet" />
                  <XRef ID="C4746745" DB="MedGen" />
                  <XRef ID="MONDO:0008762" DB="MONDO" />
                  <XRef Type="MIM" ID="203780" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="5722" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="2022" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Benign familial hematuria</ElementValue>
                    <XRef ID="Benign+Familial+Hematuria/794" DB="Genetic Alliance" />
                    <XRef ID="236421001" DB="SNOMED CT" />
                  </Name>
                  <XRef ID="C0241908" DB="MedGen" />
                  <XRef ID="MONDO:0957317" DB="MONDO" />
                  <XRef Type="Phenotypic series" ID="PS141200" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="47077" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="2022" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Benign familial hematuria</ElementValue>
                    <XRef ID="Benign+Familial+Hematuria/794" DB="Genetic Alliance" />
                    <XRef ID="236421001" DB="SNOMED CT" />
                  </Name>
                  <XRef ID="C0241908" DB="MedGen" />
                  <XRef ID="MONDO:0957317" DB="MONDO" />
                  <XRef Type="Phenotypic series" ID="PS141200" DB="OMIM" />
                </Trait>
                <Trait ID="282" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Alport syndrome recessive type</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Nephropathy and deafness</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive Alport syndrome</ElementValue>
                    <XRef ID="MONDO:0008762" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">COL4A4 Alport Syndrome and Thin Basement Membrane Nephropathy</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE</ElementValue>
                    <XRef Type="MIM" ID="203780" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0003" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0002" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0004" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0001" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0005" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0011" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0001" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0002" DB="OMIM" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">ATS2</ElementValue>
                    <XRef Type="MIM" ID="203780" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                    <XRef ID="NBK1207" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="625" />
                    <XRef ID="625" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="keyword">COL4A3-Related Nephropathy</Attribute>
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="keyword">COL4A4-Related Nephropathy</Attribute>
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301386</ID>
                    <ID Source="BookShelf">NBK1207</ID>
                  </Citation>
                  <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                    <ID Source="PubMed">22166944</ID>
                  </Citation>
                  <XRef ID="63" DB="Orphanet" />
                  <XRef ID="88919" DB="Orphanet" />
                  <XRef ID="C4746745" DB="MedGen" />
                  <XRef ID="MONDO:0008762" DB="MONDO" />
                  <XRef Type="MIM" ID="203780" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="424759" DB="ClinVar" />
          <XRef ID="CA067706" DB="ClinGen" />
          <XRef Type="rs" ID="1553676221" DB="dbSNP" />
        </XRefList>
        <FunctionalConsequence Value="mutation affecting polypeptide function">
          <XRef ID="SO:1000117" DB="Sequence Ontology" />
        </FunctionalConsequence>
      </SimpleAllele>
      <SimpleAllele AlleleID="223747" VariationID="242442">
        <GeneList>
          <Gene Symbol="COL4A4" FullName="collagen type IV alpha 4 chain" GeneID="1286" HGNC_ID="HGNC:2206" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>2q36.3</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="226967360" stop="227164488" display_start="226967360" display_stop="227164488" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="227867426" stop="228029274" display_start="227867426" display_stop="228029274" Strand="-" />
            </Location>
            <OMIM>120131</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_000092.5(COL4A4):c.2320G&gt;C (p.Gly774Arg)</Name>
        <CanonicalSPDI>NC_000002.12:227059467:C:G</CanonicalSPDI>
        <VariantType>single nucleotide variant</VariantType>
        <Location>
          <CytogeneticLocation>2q36.3</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227059468" stop="227059468" display_start="227059468" display_stop="227059468" variantLength="1" positionVCF="227059468" referenceAlleleVCF="C" alternateAlleleVCF="G" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="227924184" stop="227924184" display_start="227924184" display_stop="227924184" variantLength="1" positionVCF="227924184" referenceAlleleVCF="C" alternateAlleleVCF="G" />
        </Location>
        <OtherNameList>
          <Name>p.Gly774Arg</Name>
        </OtherNameList>
        <ProteinChange>G774R</ProteinChange>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.227924184C&gt;G" Assembly="GRCh37">
              <Expression>NC_000002.11:g.227924184C&gt;G</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.227059468C&gt;G" Assembly="GRCh38">
              <Expression>NC_000002.12:g.227059468C&gt;G</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_011592.1" sequenceAccession="NG_011592" sequenceVersion="1" change="g.110092G&gt;C">
              <Expression>NG_011592.1:g.110092G&gt;C</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_000092.5" sequenceAccession="NM_000092" sequenceVersion="5" change="c.2320G&gt;C" MANESelect="true">
              <Expression>NM_000092.5:c.2320G&gt;C</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_000083.3" sequenceAccession="NP_000083" sequenceVersion="3" change="p.Gly774Arg">
              <Expression>NP_000083.3:p.Gly774Arg</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_231" sequenceAccession="LRG_231">
              <Expression>LRG_231:g.110092G&gt;C</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_231t1" sequenceAccession="LRG_231t1">
              <Expression>LRG_231t1:c.2320G&gt;C</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_231p1" sequenceAccession="LRG_231p1" change="p.Gly774Arg">
              <Expression>LRG_231p1:p.Gly774Arg</Expression>
            </ProteinExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2024-01-23" DateCreated="2018-05-10" MostRecentSubmission="2024-07-10" NumberOfSubmissions="10" NumberOfSubmitters="10">
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description>Conflicting classifications of pathogenicity</Description>
            <Explanation DataSource="ClinVar" Type="public">Pathogenic(2); Likely pathogenic(6); Uncertain significance(1)</Explanation>
            <Citation Type="general">
              <ID Source="PubMed">17396119</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">24033287</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">24854265</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">26934356</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">28632965</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">29496980</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">33048202</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">33532864</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">33838161</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">34584596</ID>
            </Citation>
            <Comment DataSource="ClinVar" Type="public">Pathogenic(2); Likely pathogenic(6); Uncertain significance(1)</Comment>
            <DescriptionHistory Dated="2022-07-22">
              <Description>Pathogenic/Likely pathogenic</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2022-03-25">
              <Description>Likely pathogenic</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2018-05-11">
              <Description>no classification for the single variant</Description>
            </DescriptionHistory>
            <ConditionList>
              <TraitSet ID="5722" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="2022" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Benign familial hematuria</ElementValue>
                    <XRef ID="Benign+Familial+Hematuria/794" DB="Genetic Alliance" />
                    <XRef ID="236421001" DB="SNOMED CT" />
                  </Name>
                  <XRef ID="C0241908" DB="MedGen" />
                  <XRef ID="MONDO:0957317" DB="MONDO" />
                  <XRef Type="Phenotypic series" ID="PS141200" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="5721" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="282" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Alport syndrome recessive type</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Nephropathy and deafness</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive Alport syndrome</ElementValue>
                    <XRef ID="MONDO:0008762" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">COL4A4 Alport Syndrome and Thin Basement Membrane Nephropathy</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE</ElementValue>
                    <XRef Type="MIM" ID="203780" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0003" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0002" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0004" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0001" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0005" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0011" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120070.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0001" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="120131.0002" DB="OMIM" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">ATS2</ElementValue>
                    <XRef Type="MIM" ID="203780" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                    <XRef ID="NBK1207" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="625" />
                    <XRef ID="625" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="keyword">COL4A3-Related Nephropathy</Attribute>
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="keyword">COL4A4-Related Nephropathy</Attribute>
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301386</ID>
                    <ID Source="BookShelf">NBK1207</ID>
                  </Citation>
                  <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                    <ID Source="PubMed">22166944</ID>
                  </Citation>
                  <XRef ID="63" DB="Orphanet" />
                  <XRef ID="88919" DB="Orphanet" />
                  <XRef ID="C4746745" DB="MedGen" />
                  <XRef ID="MONDO:0008762" DB="MONDO" />
                  <XRef Type="MIM" ID="203780" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="6750" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="13255" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Alport syndrome</ElementValue>
                    <XRef ID="MONDO:0018965" DB="MONDO" />
                    <XRef Type="Phenotypic series" ID="PS301050" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Hemorrhagic familial nephritis</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Hemorrhagic hereditary nephritis</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Congenital hereditary hematuria</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="5785" />
                    <XRef ID="5785" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <XRef ID="63" DB="Orphanet" />
                  <XRef ID="C1567741" DB="MedGen" />
                  <XRef ID="MONDO:0018965" DB="MONDO" />
                  <XRef Type="Phenotypic series" ID="PS301050" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="43186" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="35567" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Hypertensive disorder</ElementValue>
                    <XRef ID="MONDO:0005044" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Hypertension</ElementValue>
                    <XRef ID="HP:0000822" DB="Human Phenotype Ontology" />
                  </Name>
                  <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2019">
                    <URL>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc6a2d33-aa04-4a04-9cde-901b744d24ca</URL>
                    <CitationText>DailyMed Drug Label, CARVEDILOL, 2019</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="NICE, 2023">
                    <URL>https://www.nice.org.uk/guidance/ng136</URL>
                    <CitationText>UK NICE Guideline NG136, Hypertension in adults: diagnosis and management, 2023</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="NICE, 2023">
                    <URL>https://www.nice.org.uk/guidance/ng133</URL>
                    <CitationText>UK NICE guideline (NG133), Hypertension in pregnancy: diagnosis and management, 2023</CitationText>
                  </Citation>
                  <XRef ID="C0020538" DB="MedGen" />
                  <XRef ID="MONDO:0005044" DB="MONDO" />
                  <XRef Type="primary" ID="HP:0000822" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0004949" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0005126" DB="Human Phenotype Ontology" />
                </Trait>
                <Trait ID="18121" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Myopia (disease)</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Myopia</ElementValue>
                    <XRef ID="HP:0000545" DB="Human Phenotype Ontology" />
                    <XRef ID="MONDO:0001384" DB="MONDO" />
                    <XRef Type="Phenotypic series" ID="PS160700" DB="OMIM" />
                  </Name>
                  <XRef ID="C0027092" DB="MedGen" />
                  <XRef ID="MONDO:0001384" DB="MONDO" />
                  <XRef Type="Phenotypic series" ID="PS160700" DB="OMIM" />
                  <XRef Type="primary" ID="HP:0000545" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0001110" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0007847" DB="Human Phenotype Ontology" />
                </Trait>
                <Trait ID="17089" Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Hearing impairment</ElementValue>
                    <XRef ID="HP:0000365" DB="Human Phenotype Ontology" />
                  </Name>
                  <Citation Type="general" Abbrev="ACMG, 2014">
                    <ID Source="PubMed">24651602</ID>
                  </Citation>
                  <XRef ID="C1384666" DB="MedGen" />
                  <XRef ID="MONDO:0005365" DB="MONDO" />
                  <XRef Type="primary" ID="HP:0000365" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0000404" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0001728" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0001729" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0001754" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0008560" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0008563" DB="Human Phenotype Ontology" />
                </Trait>
                <Trait ID="21924" Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Hematuria</ElementValue>
                    <XRef ID="HP:0000790" DB="Human Phenotype Ontology" />
                  </Name>
                  <XRef ID="C0018965" DB="MedGen" />
                  <XRef Type="primary" ID="HP:0000790" DB="Human Phenotype Ontology" />
                </Trait>
                <Trait ID="18150" Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Proteinuria</ElementValue>
                    <XRef ID="HP:0000093" DB="Human Phenotype Ontology" />
                    <XRef ID="MONDO:0003634" DB="MONDO" />
                  </Name>
                  <XRef ID="C0033687" DB="MedGen" />
                  <XRef ID="MONDO:0003634" DB="MONDO" />
                  <XRef Type="primary" ID="HP:0000093" DB="Human Phenotype Ontology" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="424759" DB="ClinVar" />
          <XRef ID="CA067692" DB="ClinGen" />
          <XRef Type="rs" ID="569681869" DB="dbSNP" />
        </XRefList>
        <AlleleFrequencyList>
          <AlleleFrequency Value="0.00003" Source="Trans-Omics for Precision Medicine (TOPMed)" />
          <AlleleFrequency Value="0.00004" Source="The Genome Aggregation Database (gnomAD)" />
          <AlleleFrequency Value="0.00007" Source="The Genome Aggregation Database (gnomAD), exomes" />
          <AlleleFrequency Value="0.00009" Source="Exome Aggregation Consortium (ExAC)" />
        </AlleleFrequencyList>
      </SimpleAllele>
      <Name>NM_000092.4(COL4A4):c.[1320_1369+2del];[2320G&gt;C]</Name>
      <VariationType>CompoundHeterozygote</VariationType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression>
            <Expression>NM_000092.4:c.[1320_1369+2del];[2320G&gt;C]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </Genotype>
    <RCVList>
      <RCVAccession Title="NM_000092.4(COL4A4):c.[1320_1369+2del];[2320G&gt;C] AND Autosomal recessive Alport syndrome" Accession="RCV000207535" Version="4">
        <ClassifiedConditionList TraitSetID="5721">
          <ClassifiedCondition DB="MedGen" ID="C4746745">Autosomal recessive Alport syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-02-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-02-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-02-27" MostRecentSubmission="2016-02-27">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26934356</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5721" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="282" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alport syndrome recessive type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephropathy and deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COL4A4 Alport Syndrome and Thin Basement Membrane Nephropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="203780" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive Alport syndrome</ElementValue>
                <XRef ID="MONDO:0008762" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATS2</ElementValue>
                <XRef Type="MIM" ID="203780" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                <XRef ID="NBK1207" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">COL4A3-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">COL4A4-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="625" />
                <XRef ID="625" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301386</ID>
                <ID Source="BookShelf">NBK1207</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22166944</ID>
              </Citation>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="88919" DB="Orphanet" />
              <XRef ID="C4746745" DB="MedGen" />
              <XRef ID="MONDO:0008762" DB="MONDO" />
              <XRef Type="MIM" ID="203780" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="492485" SubmissionDate="2016-02-05" DateLastUpdated="2016-02-27" DateCreated="2016-02-27">
        <ClinVarSubmissionID localKey="NM_000092.4:c.[2320G&gt;C];[1320_1369+2del]|OMIM:203780" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000262764" DateUpdated="2016-02-27" DateCreated="2016-02-27" Type="SCV" Version="2" SubmitterName="Genetic Diagnostic Laboratory, University of Szeged" OrgID="505693" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Genetic Diagnostic Assertion Criteria ver.1 Jan.2016</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/a9imcqff/gdl_assertion_criteria_ver_1_jan_2016.doc</URL>
            <CitationText>GDL Assertion Criteria ver 1 Jan 2016.doc</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithSegregationObserved="1" NumFamiliesWithVariant="1">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <NamePlatform>IonTorrent PGM</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <Genotype>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="COL4A4" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_000092.4:c.2320G&gt;C</Attribute>
            </AttributeSet>
            <AttributeSet>
              <Attribute Type="HGVS">NM_000092.4:c.2320G&gt;C</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="COL4A4" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_000092.4:c.1320_1369+2del</Attribute>
            </AttributeSet>
            <AttributeSet>
              <Attribute Type="HGVS">NM_000092.4:c.1320_1369+2del</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <VariationType>CompoundHeterozygote</VariationType>
        </Genotype>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="203780" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Alport01</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="492485" TraitType="Disease" MappingType="XRef" MappingValue="203780" MappingRef="OMIM">
        <MedGen CUI="C4746745" Name="Autosomal recessive Alport syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

